Parkinson's Disease Trial, Recruiting NCT06914466 Sponsor: Xuanwu Hospital, Beijing Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06914466
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Parkinson's disease according to one of two recognised sets of diagnostic guidelines (the UK PD Society Brain Bank criteria or the 2015 MDS criteria), with the diagnosis confirmed by three neurologists who specialise in movement disorders.
  • People who have had a specific type of deep brain stimulation surgery on both sides of the brain, using a device called the Medtronic Percept™ PC, targeting an area of the brain called the subthalamic nucleus (STN).
  • People who are able to attend follow-up appointments and take part in clinical assessments after their surgery.

Who may not be able to join:

  • People who have had other types of brain surgery (aside from the DBS surgery described above).
  • People whose Parkinson's-like symptoms are caused by something other than Parkinson's disease itself, such as secondary Parkinsonism or a related but different condition known as Parkinsonism-plus syndrome.
  • People who have other conditions affecting the brain, spinal cord, or nerves.
  • People who have serious health conditions in other parts of the body, or who would not be able to tolerate the clinical assessments involved in the trial.
  • People who have a severe mental health condition.
  • People who are unable to give informed consent due to difficulties with thinking or communication, or who choose not to sign the consent form.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: yuqing Zhang, Xuanwu Hospital, Beijing

Phone: 010-83922345

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xuanwu Hospital, Beijing
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
1 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Duration of REM sleep stage; Subjective Sleep Quality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov